AVITA Medical, Inc. (RCEL)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 8M 16M 24M Q3 '18: 269K Q4 '18: 1M Q1 '19: 1.7M Q2 '19: 2.5M Q3 '19: 3.2M Q4 '19: 3.3M Q1 '20: 3.9M Q2 '20: 3.9M Q3 '20: 5.1M Q4 '20: 5.1M Q1 '21: 8.8M Q2 '21: 10.3M Q3 '21: 7M Q4 '21: 6.9M Q1 '22: 7.5M Q2 '22: 8.3M Q3 '22: 9.1M Q4 '22: 9.5M Q1 '23: 10.6M Q2 '23: 11.8M Q3 '23: 13.6M Q4 '23: 14.2M Q1 '24: 11.1M Q2 '24: 15.2M Q3 '24: 19.4M Q4 '24: 18.2M Q1 '25: 18.3M Q2 '25: 18.2M Q3 '25: 16.9M Q4 '25: 17.4M Q1 '26: 19.1M Q2 '26: 21.5M Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Gross Profit Quarterly

0 7M 14M 21M Q3 '18: 37K Q4 '18: 798K Q1 '19: 1.4M Q2 '19: 1.9M Q3 '19: 2.6M Q4 '19: 2.4M Q1 '20: 3.2M Q2 '20: 3M Q3 '20: 4.1M Q4 '20: 4.3M Q1 '21: 6.6M Q2 '21: 8.3M Q3 '21: 5.9M Q4 '21: 6.1M Q1 '22: 5.8M Q2 '22: 6.9M Q3 '22: 7.6M Q4 '22: 8.1M Q1 '23: 8.9M Q2 '23: 9.5M Q3 '23: 11.5M Q4 '23: 12.4M Q1 '24: 9.6M Q2 '24: 13.1M Q3 '24: 16.4M Q4 '24: 16.1M Q1 '25: 15.7M Q2 '25: 14.9M Q3 '25: 13.9M Q4 '25: 14.3M Q1 '26: 15.7M Q2 '26: 17.8M Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Operating Income Quarterly

-18M -12M -6M 0 6M 12M 18M Q3 '18: -5.1M Q4 '18: -6.3M Q1 '19: -6.7M Q2 '19: -7.5M Q3 '19: -3.7M Q4 '19: -10.6M Q1 '20: -15.4M Q2 '20: -13M Q3 '20: -10.2M Q4 '20: -5.6M Q1 '21: -6M Q2 '21: -4.7M Q3 '21: -5.9M Q4 '21: -8.5M Q1 '22: -9.5M Q2 '22: -6.4M Q3 '22: -5.7M Q4 '22: -5.9M Q1 '23: -9.9M Q2 '23: -11.2M Q3 '23: -9.3M Q4 '23: -12.3M Q1 '24: -17.2M Q2 '24: -15.6M Q3 '24: -13.8M Q4 '24: -10M Q1 '25: -11.8M Q2 '25: -11.1M Q3 '25: -9.2M Q4 '25: -10.4M Q1 '26: -8.8M Q2 '26: -6.9M Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Net Income Quarterly

-21M -14M -7M 0 7M 14M 21M Q3 '18: -5M Q4 '18: -6.3M Q1 '19: -6.2M Q2 '19: -7.6M Q3 '19: -3.6M Q4 '19: -10.5M Q1 '20: -15M Q2 '20: -12.9M Q3 '20: -10.2M Q4 '20: -5.6M Q1 '21: -6M Q2 '21: -4.7M Q3 '21: -5.9M Q4 '21: -8.5M Q1 '22: -9.5M Q2 '22: -6.3M Q3 '22: -5.6M Q4 '22: -5.4M Q1 '23: -9.2M Q2 '23: -10.4M Q3 '23: -8.7M Q4 '23: -7.1M Q1 '24: -18.7M Q2 '24: -15.4M Q3 '24: -16.2M Q4 '24: -11.6M Q1 '25: -13.9M Q2 '25: -9.9M Q3 '25: -13.2M Q4 '25: -11.6M Q1 '26: -10.6M Q2 '26: -7.7M Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Cost of Revenue Quarterly

0 1.5M 3M 4.5M Q3 '18: 232K Q4 '18: 242K Q1 '19: 292K Q2 '19: 505K Q3 '19: 619K Q4 '19: 846K Q1 '20: 634K Q2 '20: 874K Q3 '20: 929K Q4 '20: 821K Q1 '21: 2.1M Q2 '21: 2.1M Q3 '21: 1.1M Q4 '21: 817K Q1 '22: 1.8M Q2 '22: 1.4M Q3 '22: 1.5M Q4 '22: 1.3M Q1 '23: 1.7M Q2 '23: 2.2M Q3 '23: 2.1M Q4 '23: 1.8M Q1 '24: 1.5M Q2 '24: 2.1M Q3 '24: 3.2M Q4 '24: 2.3M Q1 '25: 2.8M Q2 '25: 3.5M Q3 '25: 3.2M Q4 '25: 3.3M Q1 '26: 3.5M Q2 '26: 3.9M Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Operating Cash Flow Quarterly

-24M -16M -8M 0 8M 16M 24M Q3 '19: -4.9M Q4 '19: -4.7M Q1 '20: -7.3M Q2 '20: -5.9M Q3 '20: -7.7M Q4 '20: -5.7M Q1 '21: -8.5M Q2 '21: -4M Q3 '21: -572K Q4 '21: -4.9M Q1 '22: -9.4M Q2 '22: -3.5M Q3 '22: -2.8M Q4 '22: -3.4M Q1 '23: -9.1M Q2 '23: -9.1M Q3 '23: -9M Q4 '23: -10.9M Q1 '24: -20.9M Q2 '24: -12.8M Q3 '24: -7.2M Q4 '24: -8.1M Q1 '25: -10.3M Q2 '25: -10.2M Q3 '25: -5.2M Q4 '25: -5.4M Q1 '26: -10.1M Q2 '26: -3.5M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Free Cash Flow Quarterly

-24M -16M -8M 0 8M 16M 24M Q3 '19: -5M Q4 '19: -4.7M Q1 '20: -7.6M Q2 '20: -6M Q3 '20: -7.9M Q4 '20: -5.9M Q1 '21: -8.9M Q2 '21: -4.1M Q3 '21: -639K Q4 '21: -4.9M Q1 '22: -9.4M Q2 '22: -3.7M Q3 '22: -2.9M Q4 '22: -3.5M Q1 '23: -9.4M Q2 '23: -9.4M Q3 '23: -9.5M Q4 '23: -11.2M Q1 '24: -22M Q2 '24: -15.4M Q3 '24: -11M Q4 '24: -9.7M Q1 '25: -10.5M Q2 '25: -10.8M Q3 '25: -6.2M Q1 '26: -10.1M Q2 '26: -3.6M Q1 '20 Q1 '21 Q1 '22 Q1 '23 Q1 '24 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q3 '18: 13.2M Q4 '18: 14.2M Q1 '19: 18.3M Q2 '19: 18.7M Q3 '19: 18.7M Q4 '19: 19.9M Q1 '20: 21.2M Q2 '20: 21.4M Q3 '20: 21.5M Q4 '20: 21.6M Q1 '21: 22.7M Q2 '21: 24.9M Q3 '21: 24.9M Q1 '22: 24.9M Q2 '22: 25M Q3 '22: 25M Q1 '23: 25.2M Q2 '23: 25.2M Q3 '23: 25.4M Q1 '24: 25.6M Q2 '24: 25.8M Q3 '24: 26M Q1 '25: 26.3M Q2 '25: 26.4M Q3 '25: 28.4M Q1 '26: 30.5M Q2 '26: 30.7M Q1 '19 Q1 '20 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.70 -1.80 -0.90 0.00 0.90 1.80 2.70 Q2 '19: -1.57 Q3 '19: -1.38 Q4 '19: -0.41 Q1 '20: 0.64 Q2 '20: 0.45 Q3 '20: 1.12 Q4 '20: 0.85 Q1 '21: 0.40 Q2 '21: 1.19 Q3 '21: 0.95 Q4 '21: 1.03 Q1 '22: 1.15 Q2 '22: 1.21 Q3 '22: 1.19 Q4 '22: 1.07 Q1 '23: 0.32 Q2 '23: -0.34 Q3 '23: -0.90 Q4 '23: -1.40 Q1 '24: -1.76 Q2 '24: -1.95 Q3 '24: -2.23 Q4 '24: -2.39 Q1 '25: -2.19 Q2 '25: -1.97 Q3 '25: -1.81 Q4 '25: -1.74 Q1 '26: -1.56 Q2 '26: -1.43 Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.